The 3rd International Conference Soy and Health 2004

Citation

(2004), "The 3rd International Conference Soy and Health 2004", Nutrition & Food Science, Vol. 34 No. 6. https://doi.org/10.1108/nfs.2004.01734fab.005

The 3rd International Conference Soy and Health 2004

The 3rd International Conference Soy and Health 2004 – this conference brings new scientific evidence on health benefits of soy, October 7 and 8, Bruges, Belgium

Newest research on soy is showing that consumption of soy may have a positive impact on inflammation parameters. Research directed by Prof. Velasquez, USA, and Prof. Santti, Finland, confirms the beneficial effects of soy on prostatitis and kidney disease. This, and other new data will be released at the 3rd International Conference Soy & Health 2004 – Clinical Evidence, Dietetic Applications, to be held in Bruges, Belgium, on October 7 and 8, 2004.

More than 400 health care professionals, people from the soy ingredient, supplement and soy food industry, and government and information services will participate in the 3rd International Conference Soy & Health 2004.

Leading soy ingredient and supplement manufacturers, and soyfood producers will present novel soy food products and applications.

The scientific program includes:

1. 1.

   Soy and heart disease and diabetes:

2. 2.
   • •

     Effect of soy protein on cholesterol and triglycerides – Maria Rosa, Lovati, Milan, Italy.

   • •

     Cardiovascular effects of the phytoestrogen genistein – Francesco Squadrito, School of Medicine, University of Messina, Italy.

   • •

     Treatment of young patients with familial hypercholesterolemia with soy – Kurt Widhalm, Medical University of Vienna, Austria.

   • •

     Soy and diabetes – Stephen L. Atkin, University of Hull, UK.

3. 3.

   Hormonal effects and osteoporosis:

4. 4.
   • •

     Hormonal substitution with plant compounds; where are we? – Jaak Janssens, Hasselt, Belgium.

   • •

     Phytoestrogens and osteoporosis – Eva Lydeking-Olsen, Institute for Optimum Nutrition, Denmark.

5. 5.

   Equol and lignans:

6. 6.
   • •

     Equol - its unique property as both a selective estrogen receptor modulator (SERM) and a selective androgen modulator (SAM) – Ken Setchell, Children’s Hospital Medical Centre, Cincinnati OH, USA.

   • •

     Lignans in soy and in isoflavone supplements – Jose Penalvo, Folkhälsan Research Center, University of Helsinki, Finland.

7. 7.

   Soy and cancer:

8. 8.
   • •

     Early soy intake and breast cancer – Mark Messina, Loma Linda University, California, USA.

   • •

     How far is soy preventive for BRCA linked hereditary breast cancer? – Yves-Jean Bignon, University of Clermont-Ferrand, France.

   • •

     Soy and prostate cancer – Ian Rowland, University of Ulster, Northern Ireland.

9. 9.

   Immunity:

10. 10.
    • •

      Soy and kidney disease – Manuel Velasquez, Washington University, USA.

    • •

      Role of soy in prostatitis – Risto Santti, University of Turku, Finland.

11. 11.

    Early exposure to soya and cognitive function:

12. 12.
    • •

      Consequences of early soy exposure on development, metabolism, body composition and health – Thomas M. Badger, Arkansas Children’s Nutrition Center & University of Arkansas for Medical Services, USA.

    • •

      Soy and cognitive function – David Hartley, King’s College, London, UK.

13. 13.

    Dietary applications and future of soy:

14. 14.
    • •

      How to introduce soy in the diet – Angie Jefferson, Bracknell, UK.

    • •

      Nutrition & Health 2020. Future scenarios for a health conscious society. role of soy – Jo Goossens, Biosense, Belgium.

For more information, visit Web site: www. soyconference.com; E-mail info@soyconference.com